Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
AT ˙ WBAG ˙ US8816242098
29,40 € ↑1,40 (5,00%)
2026-06-04
CENA AKCJI
SecurityAT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionIMC-Chicago, LLC
Latest Disclosed Ownership89,569 shares
Latest Disclosed Value $ 2,697,818
IMC-Chicago, LLC ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 5, 2026 - IMC-Chicago, LLC filed a 13F-HR form disclosing ownership of 89,569 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (AT:TEVA) valued at $2,266,096 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 4, 2025 disclosing 0 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). The current value of the position is $2,633,329 USD.

IMC-Chicago, LLC has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 456,000 of underlying shares valued at $13,734,720 USD and put options representing 273,100 of underlying shares valued at $8,225,772 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 89,569 89,569 2,698 0.0009
2025-11-04 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -92,126 -100.00 0 -100.00
2025-07-22 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 92,126 20,170 28.03 1,544 39.73 0.0007
2025-04-14 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 71,956 71,956 1,106 0.0006
2025-01-27 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -33,328 -100.00 0 -100.00
2024-10-25 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 33,328 -36,977 -52.60 601 -47.46 0.0003
2024-07-15 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 70,305 45,157 179.56 1,142 222.60 0.0007
2024-04-12 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 25,148 25,148 355 0.0002
2024-02-09 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -91,254 -100.00 0 -100.00
2023-10-12 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 91,254 -41,676 -31.35 931 -7.00 0.0008
2023-07-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 132,930 -96,919 -42.17 1,001 -50.84 0.0009
2023-04-24 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 229,849 125,574 120.43 2,034 114.11 0.0024
2023-04-24 2022-12-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 104,275 27,762 36.28 951 53.97 0.0015
2023-02-09 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 104,275 27,762 1 0.0000
2022-11-08 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 76,513 -110,485 -59.08 617 -56.12 0.0008
2022-08-05 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 186,998 56,245 43.02 1,406 14.50 0.0020
2022-04-19 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 130,753 -110,134 -45.72 1,228 -36.37 0.0012
2022-02-08 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 240,887 130,638 118.49 1,930 79.70 0.0016
2021-11-05 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 110,249 -21,428 -16.27 1,074 -17.64 0.0011
2021-08-06 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 131,677 49,265 59.78 1,304 37.12 0.0016
2021-05-14 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 82,412 82,412 951 0.0014
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -22,168 -100.00 0 -100.00
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 22,168 22,168 348 0.0013
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 456,000 -51.51 13,735 -53.20 n/a n/a n/a
2026-01-29 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 940,400 44.61 29,350 123.42 n/a n/a n/a
2025-11-04 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 650,300 15.28 13,136 38.95 n/a n/a n/a
2025-07-22 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 564,100 16.33 9,454 26.87 n/a n/a n/a
2025-04-14 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 484,900 -70.16 7,453 -79.19 n/a n/a n/a
2025-01-27 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,625,100 150.52 35,817 206.42 n/a n/a n/a
2024-10-25 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 648,700 -2.23 11,690 8.42 n/a n/a n/a
2024-07-15 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 663,500 95.26 10,782 124.89 n/a n/a n/a
2024-04-12 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 339,800 -21.87 4,795 5.59 n/a n/a n/a
2024-02-09 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 434,900 -5.15 4,540 -2.91 n/a n/a n/a
2023-10-12 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 458,500 292.55 4,677 431.97 n/a n/a n/a
2023-07-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 116,800 -43.68 880 -52.10 n/a n/a n/a
2023-04-24 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 207,400 -42.83 1,835 -44.53 n/a n/a n/a
2023-04-24 2022-12-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 362,800 -11.21 3,309 0.33 n/a n/a n/a
2023-02-09 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 362,800 3 n/a n/a n/a
2022-11-08 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 408,600 17.35 3,297 25.94 n/a n/a n/a
2022-08-05 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 348,200 -6.04 2,618 -24.77 n/a n/a n/a
2022-04-19 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 370,600 -33.57 3,480 -22.13 n/a n/a n/a
2022-02-08 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 557,900 22.11 4,469 0.43 n/a n/a n/a
2021-11-05 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 456,900 35.70 4,450 33.51 n/a n/a n/a
2021-08-06 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 336,700 -7.17 3,333 -20.38 n/a n/a n/a
2021-05-14 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 362,700 -8.36 4,186 9.61 n/a n/a n/a
2021-02-17 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 395,800 38.83 3,819 48.66 n/a n/a n/a
2020-11-17 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 285,100 9.78 2,569 -19.77 n/a n/a n/a
2020-08-14 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 259,700 -42.56 3,202 -21.13 n/a n/a n/a
2020-05-14 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 452,100 22.99 4,060 12.72 n/a n/a n/a
2020-02-13 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 367,600 83.98 3,602 161.96 n/a n/a n/a
2019-11-12 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 199,800 -13.09 1,375 -35.20 n/a n/a n/a
2019-08-15 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 229,900 194.37 2,122 73.22 n/a n/a n/a
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 78,100 -64.39 1,225 -63.78 n/a n/a n/a
2019-04-24 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 219,300 3,382 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 273,100 -61.58 8,226 -62.92 n/a n/a n/a
2026-01-29 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 710,800 40.59 22,184 117.21 n/a n/a n/a
2025-11-04 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 505,600 -7.60 10,213 11.36 n/a n/a n/a
2025-07-22 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 547,200 35.41 9,171 47.66 n/a n/a n/a
2025-04-14 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 404,100 -53.65 6,211 -67.67 n/a n/a n/a
2025-01-27 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 871,800 104.50 19,214 150.15 n/a n/a n/a
2024-10-25 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 426,300 0.02 7,682 10.92 n/a n/a n/a
2024-07-15 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 426,200 35.99 6,926 56.60 n/a n/a n/a
2024-04-12 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 313,400 -14.32 4,422 15.82 n/a n/a n/a
2024-02-09 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 365,800 12.94 3,819 15.59 n/a n/a n/a
2023-10-12 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 323,900 81.05 3,304 145.21 n/a n/a n/a
2023-07-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 178,900 -62.74 1,347 -68.30 n/a n/a n/a
2023-04-24 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 480,200 45.21 4,250 40.93 n/a n/a n/a
2023-04-24 2022-12-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 330,700 -12.37 3,016 -1.02 n/a n/a n/a
2023-02-09 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 330,700 3 n/a n/a n/a
2022-11-08 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 377,400 -29.84 3,046 -24.70 n/a n/a n/a
2022-08-05 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 537,900 22.39 4,045 -1.99 n/a n/a n/a
2022-04-19 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 439,500 -19.14 4,127 -5.19 n/a n/a n/a
2022-02-08 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 543,500 48.90 4,353 22.45 n/a n/a n/a
2021-11-05 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 365,000 2.41 3,555 0.77 n/a n/a n/a
2021-08-06 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 356,400 18.01 3,528 1.23 n/a n/a n/a
2021-05-14 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 302,000 17.83 3,485 40.92 n/a n/a n/a
2021-02-17 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 256,300 52.02 2,473 62.80 n/a n/a n/a
2020-11-17 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 168,600 -11.82 1,519 -35.55 n/a n/a n/a
2020-08-14 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 191,200 -42.81 2,357 -21.49 n/a n/a n/a
2020-05-14 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 334,300 52.16 3,002 39.43 n/a n/a n/a
2020-02-13 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 219,700 -19.82 2,153 14.22 n/a n/a n/a
2019-11-12 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 274,000 19.70 1,885 -10.79 n/a n/a n/a
2019-08-15 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 228,900 119.04 2,113 28.92 n/a n/a n/a
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 104,500 -6.28 1,639 -4.65 n/a n/a n/a
2019-04-24 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 111,500 1,719 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.